As Digital Journal has recently reported Microsoft has recently launched Healthcare NeXT, which is a cloud-based, artificial intelligence and research project with the aim of fostering digital tools to encourage people to lead healthier lives as well as offering analytics to support healthcare research.
Part of the research that Microsoft is undertaking is into cancer. This fits with a different approach that the technology company is taking to a long-standing biological research area. This is with seeing living cells, like cancer mutations, as computers. The concept is that cancer should be regarded as a ‘glitch’ in the system and potentially it is something that can be reprogrammed.
Microsoft’s biological laboratories have two different subsystems undertaking research. The first area is with modelling the computational processes (traditionally ‘biochemistry’) that occur within a living cell. The second is with constructing a tool for researchers to use so they can create their own computerized models of biological systems.
Commenting on this aspect of cancer research, Jonathan Dry, who is a principal scientist at [pharmeceutical company] AstraZeneca, told Fast Company: “I’m hoping this is the beginning of changing the way we do drug discovery.”
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Microsoft enters race to find cancer cure